Core stack: Glutathione + arbutin/TXA + barrier supports
These medications mimic the effects of the GLP-1 hormone which helps regulate appetite, digestion, and insulin release from the pancreas
Dr Joshua Czech MBChB A graduate of the University of Cape Town, Dr Joshua Czech has experience in emergency medicine and general practice
Nearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) will roll out a new, temporary program covering GLP-1s for obesity for people with Medicare
5 Challenges and considerations Despite the tremendous promise of GLP-1-based therapies, challenges remain
Several clinical trials are underway to discover why GLP-1 users with disorders and addiction report diminished cravings, though scientists have suggested a theory that the medications may interact with parts of the brain that produce dopaminealso known as the feel-good hormone, which has been linked to addictionin a way that makes the dopamine effects of drugs and alcohol less intense